Vectura Ltd.
This article was originally published in Start Up
Executive Summary
Given the need to find more effective, and faster, ways of administering a widening range of drugs, many companies are looking to improve pulmonary drug delivery. One of Vectura's goals is improving existing dry powder inhalation systems.
You may also be interested in...
Inhalable Drug Delivery
Over the past few years, the drug delivery industry has seen a major change in its basic structure. Nowhere is this more true than in the subsegment of inhalable drug delivery. One of the big drivers of the change: drug delivery companies angling for market share in partnering.
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”
The New Antibodies Revolutionizing Medicine
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.